Substance use, socio‐demographic characteristics, and self‐rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study

Author:

Black Emma1234ORCID,Bruno Raimondo35,Mammen Kristie14,Mills Llewellyn124,Siefried Krista J3467,Deacon Rachel M124,Shakeshaft Anthony38,Dunlop Adrian J491011ORCID,Ezard Nadine3467,Montebello Mark23412,Childs Steven413,Reid David414,Holmes Jennifer14,Lintzeris Nicholas124ORCID

Affiliation:

1. Drug and Alcohol Services, South Eastern Sydney Local Health District Sydney NSW

2. Central Clinical School the University of Sydney Sydney NSW

3. National Drug and Alcohol Research Centre, University of New South Wales Sydney NSW

4. NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN), NSW Ministry of Health Sydney NSW

5. The University of Tasmania Hobart TAS

6. National Centre for Clinical Research on Emerging Drugs University of New South Wales Sydney NSW

7. Alcohol and Drug Service St Vincent's Hospital Sydney Sydney NSW

8. The Poche Centre for Indigenous Health the University of Queensland Brisbane QLD

9. Drug and Alcohol Clinical Services, Hunter New England Local Health District Newcastle NSW

10. The University of Newcastle Newcastle NSW

11. Hunter Medical Research Institute Newcastle NSW

12. Drug and Alcohol Services, North Sydney Local Health District Sydney NSW

13. Drug and Alcohol Services, Central Coast Local Health District Gosford NSW

14. Drug and Alcohol Services, Illawarra Shoalhaven Local Health District Wollongong NSW

Abstract

AbstractObjectiveTo investigate the demographic characteristics, substance use, and self‐rated health of people entering treatment in New South Wales public health services for alcohol, amphetamine‐type stimulants, cannabis, cocaine, or opioids use, by principal drug of concern.DesignBaseline findings of a cohort study; analysis of data in patient electronic medical records and NSW minimum data set for drug and alcohol treatment services.Setting, participantsPeople completing initial Australian Treatment Outcomes Profile (ATOP) assessments on entry to publicly funded alcohol and other drug treatment services in six NSW local health districts/networks, 1 July 2016 – 30 June 2019.Main outcome measuresSocio‐demographic characteristics, and substance use and self‐rated health (psychological, physical, quality of life) during preceding 28 days, by principal drug of concern.ResultsOf 14 087 people included in our analysis, the principal drug of concern was alcohol for 6051 people (43%), opioids for 3158 (22%), amphetamine‐type stimulants for 2534 (18%), cannabis for 2098 (15%), and cocaine for 246 (2%). Most people commencing treatment were male (9373, 66.5%), aged 20–39 years (7846, 50.4%), and were born in Australia (10 934, 86.7%). Polysubstance use was frequently reported, particularly by people for whom opioids or amphetamine‐type stimulants were the principal drugs of concern. Large proportions used tobacco daily (53–82%, by principal drug of concern group) and reported poor psychological health (47–59%), poor physical health (32–44%), or poor quality of life (43–52%).ConclusionsThe prevalence of social disadvantage and poor health is high among people seeking assistance with alcohol, amphetamine‐type stimulants, cannabis, cocaine, or opioids use problems. Given the differences in these characteristics by principal drug of concern, health services should collect comprehensive patient information during assessment to facilitate more holistic, tailored, and person‐centred care.

Funder

South Eastern Sydney Local Health District

Publisher

Wiley

Subject

General Medicine

Reference28 articles.

1. Australian Institute of Health and Welfare.Impact of alcohol and illicit drug use on the burden of disease and injury in Australia: Australian Burden of Disease Study 2011 (Cat. no. BOD 19). 29 Mar2018.https://www.aihw.gov.au/reports/burden‐of‐disease/impact‐alcohol‐illicit‐drug‐use‐on‐burden‐disease(viewed Mar 2023).

2. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. United Nations.World drug report 2021 (United Nations publication sales no. E.21.XI.8). 24 June2021.https://www.unodc.org/unodc/en/data‐and‐analysis/wdr2021.html(viewed Mar 2023).

4. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. Drug use;Ritchie H;Our World in Data,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3